KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).

BMJ · 2025-Oct-29 · PMID 41224473

Panel Heart_failure_incidence_development_提取完成待 EXE 对齐验证

heart failure incidence

Fig 2 Cumulative hazard estimates and log-rank test of PREVENT-TAHA8 trial’s endpoints: heart failure (HF) incidence (development) (primary endpoint), readmission to hospital for HF, all cause mortality, cardiovascular mortality, readmission to hospital for myocardial infarction (MI), and composite endpoint of cardiovascular mortality and readmission to hospital for HF or MI. An interactive version of this graphic and downloadable data are available at https://public.flourish.studio/visualisation/25452455/

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.89
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-23T17:59:34+00:00